|
BQS-Bundesauswertung
2006 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Koronarchirurgie,
isoliert |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Übersicht Qualitätsindikatoren |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Übersicht Qualitätsindikatoren |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fälle
Gesamt |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Anzahl koronarchirurgische Operationen |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
47.391 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Anzahl Patienten, die in ihrer ersten Operation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
isoliert koronarchirurgisch operiert wurden |
|
|
|
|
|
|
|
|
|
|
|
|
|
47.191 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ergebnis |
|
|
Ergebnis |
|
Referenz- |
|
|
|
|
|
Qualitätsindikator |
|
|
|
|
|
|
|
|
|
|
Anzahl |
|
|
|
% |
|
|
bereich |
|
Seite |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
QI 1: Verwendung der linksseitigen |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Arteria mammaria interna |
|
|
|
|
|
37.865 / 41.601 |
|
|
91,02% |
|
>= 81,7% |
|
|
1.1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
QI 2: Postoperative Mediastinitis |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
bei Patienten mit elektiver oder |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
dringlicher Operationsindikation ohne |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
präoperative Mediastinitis bzw. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Wundinfektion des Thorax |
|
|
|
|
|
|
602 / 41.582 |
|
|
1,45% |
|
nicht definiert |
|
|
1.3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
bei Patienten mit Risikoklasse 0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
oder Risikoklasse 1 |
|
|
|
|
|
|
|
|
529 / 38.569 |
|
|
1,37% |
|
|
<= 3,6% |
|
|
1.6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
QI 3: Postoperative |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Retentionsstörung |
|
|
|
|
|
|
|
1.028 / 37.113 |
|
|
2,77% |
|
|
<= 7% |
|
|
1.9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
QI 4: Neurologische Komplikationen |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
bei Patienten ohne neurologische |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Vorerkrankungen und Dauer des |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
zerebrovaskulären Ereignisses |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
zwischen > 24 h bis <= 72 h |
|
|
|
|
|
|
101 / 39.339 |
|
|
0,26% |
|
nicht definiert |
|
1.12 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
bei Patienten ohne neurologische |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Vorerkrankungen und Dauer des |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
zerebrovaskulären Ereignisses > 72 h |
|
|
|
|
462 / 39.339 |
|
|
1,17% |
|
|
<= 3,2% |
|
1.12 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
QI 5: Letalität |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
In-Hospital-Letalität bei allen Patienten, |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
die in ihrer ersten Operation isoliert |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
koronarchirurgisch operiert wurden |
|
|
|
1.609 / 47.191 |
|
|
3,41% |
|
nicht definiert |
|
1.16 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
In-Hospital-Letalität bei Patienten mit |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
elektiver oder dringlicher Operations- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
indikation |
|
|
|
|
|
|
|
|
|
|
975 / 41.631 |
|
|
2,34% |
|
nicht definiert |
|
1.16 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
In-Hospital-Letalität bei Patienten mit |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Notfall- oder Notfall (Reanimation/ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ultima ratio)-Operationen |
|
|
|
|
|
|
|
634 / 5.560 |
|
|
11,40% |
|
nicht definiert |
|
1.16 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Verhältnis der beobachteten In-Hospital- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Letalität zur erwarteten In-Hospital- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Letalität nach logistischem KCH-SCORE |
|
|
|
|
|
|
|
|
|
1,04 |
|
nicht definiert |
|
1.22 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Risikoadjustierte In-Hospital-Letalität |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
nach logistischem KCH-SCORE |
|
|
|
|
|
|
|
|
|
|
3,46% |
|
|
<= 6,7% |
|
1.22 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Verhältnis der beobachteten In-Hospital- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Letalität zur erwarteten In-Hospital- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Letalität nach logistischem EuroSCORE |
|
|
|
|
|
|
|
|
|
0,52 |
|
nicht definiert |
|
1.26 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Risikoadjustierte In-Hospital-Letalität |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
nach logistischem EuroSCORE |
|
|
|
|
|
|
|
|
|
|
1,76% |
|
nicht definiert |
|
1.26 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
30-Tage-Letalität: Follow-up-Rate |
|
|
|
|
35.490 / 47.191 |
|
|
75,21% |
|
nicht definiert |
|
1.29 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
30-Tage-Letalität in Krankenhäusern |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
mit einer Follow-up-Rate >= 97% |
|
|
|
|
|
958 / 26.453 |
|
|
3,62% |
|
nicht definiert |
|
1.30 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
30-Tage-Letalität in Krankenhäusern |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
mit einer Follow-up-Rate >= 97% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
bei Patienten mit vollständiger |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dokumentation zum EuroSCORE |
|
|
|
|
|
913 / 25.493 |
|
|
3,58% |
|
nicht definiert |
|
1.32 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
© BQS 2007 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
31.05.2007 / 2006 - D4899-L39484-P19795 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
